The effects of repeated morphine exposure on mu opioid receptor number and affinity in C57BL/6J and DBA/2J mice

Life Sciences

Volumn 61, Issue 20, 1997, Pages 2057-2064

  Petruzzi, Rebecca ^a   Ferraro, Thomas N ^a   Kürschner, Veit C ^a   Golden, Gregory T ^b,c   Berrettini, Wade H ^a,d  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d University of PA   (United States)

Author keywords

C57BL 6J mice; DBA 2J mice; Downregulation; Morphine; mu opioid receptors

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MORPHINE; MORPHINE SULFATE; MU OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE TIME EFFECT RELATION; DRUG RECEPTOR BINDING; MALE; MORPHINE TOLERANCE; NONHUMAN; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; STRAIN DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BRAIN; CORPUS STRIATUM; DOWN-REGULATION; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALINS; FRONTAL LOBE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MORPHINE; RECEPTORS, OPIOID, MU; REGRESSION ANALYSIS;

ANIMALIA;

EID: 0030828550     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00864-3     Document Type: Article

References (28)

1. G.P. HOROWITZ, G. WHITNEY, J.C. SMITH, and F.K. STEPHAN, Psychopharmacolgy. 52 119-122 (1977).
2. J.K. BELKNAP, J.C. CRABBE, J. RIGGAN, and L.A. O'TOOLE, Psychopharmacology. 12 352-358 (1993).
3. W.H. BERRETTINI, T.N. FERRARO, R.C. ALEXANDER, A.M. BUCHBERG, and W.H. VOGEL, Nat. Genet. 7 54-58 (1994).
4. E.S. LANDER, and D. BOTSTEIN, Genetics 121 185-189 (1989).
5. B. GIROS, M. POHL, J. ROCHELLE, and M. SELDIN, Life Sci. 56 PL 369-375 (1995).
6. C.A. KOZAK, J. FILIE, M.C. ADAMSON, Y. CHEN, and L. YU, Genomics 21 659-661 (1994).
7. J.K. BELKNAP, J.S. MOGIL, M.L. HELMS, S.P. RICHARDS, L.A. O'TOOLE, S.E. BERGESON, and K.J. BUCK, Life Sci. 57 PL 117-124 (1995).
8. G.W. PASTERNAK, The Opiate Receptors Humana Press, New Jersey (1988).
9. B.C. YOBURN, V. SIERRA, and K. LUTFY, Eur. J. Pharmacol. 170 193-200 (1989).
10. P.S. PUTTFARKEN, and B.M. COX, Life Sci. 45 1937-1942(1989).
11. P.W. LAW, D.S. HOM, and H.H. LOH, Mol. Pharmacol. 24 413-424 (1983).
12. M.E.A. REITH, H. SERSHEN, C. VADASZ, and A. LAJTHA, Eur. J. Pharmacol. 74 377-380 (1981).
13. L.L. WERLING, P.N. MCMAHON, and B.M. COX, Proc. Natl. Acad. Sci. USA 86 6393-6397 (1989).
14. A.S. MOSKOWTTZ, and R.R. GOODMAN, Brain Res. 360 108-116(1985a).
15. T.S. SHIPPENBERG, and R. BALS-KUBIK Neurobiology of Opioids, O.F.X. Almeida, and T.S. Shippenberg (Eds.), 331-350, Springer-Verlag, Berlin (1989).
16. R.L. SIDMAN, J.B. ANGEVINE, and E.T. PIERCE, Atlas of the mouse brain and spinal cord Harvard University Press, Cambridge (1971).
17. D.B. BYLUND, and H.I. YAMAMURA Methods in Neurotransmitter Receptor Analysis, H.I. Yamamura, S.J. Enna, and M.J. Kuhar (Eds), 1-35, Raven Press, New York (1990).
18. O.H. LOWRY, N.J. ROSEBROUGH, A.L. FARR, and R.J. RANDALL, J. Biol. Chem. 193 265-275 (1951).
19. P.D. ORAHOVATS, C.A. WINTER, and E.G. LEHMAN, J. Pharmacol. Exp. Ther. 109 413-416 (1953).
20. A. REGGIANI, F. BATTAINI, H. KOBAYASHI, P. SPANO, and M. TRABUCCHI, Brain Res. 189 289-294 (1980).
21. G.W. PASTERNAK, Clin. Neuropharmacol. 16 1-18 (1993).
22. B.C. YOBURN, B. BILLINGS, AND A. DUTTAROY, J. Pharmacol. Exp. Ther. 265 314-320 (1993).
23. S.K. SHARMA, W.A. KLEE, and M. NIRENBERG, Proc. Natl. Acad. Sci. USA 72 3092-3096 (1975).
24. B.D. CARTER, and F. MEDZIHRADSKY, Proc. Natl. Acad. Sci. USA 90 4062-4066 (1993).
25. S.K. SHARMA, M. NIRENBERG, and W.A. KLEE, Proc. Natl. Acad. Sci. USA 72 590-594 (1975).
26. D. PAUL, R.J. BADNAR, M. A. GISTRAK, AND G.W. PASTERNAK, Eur. J. Pharmacol. 168 307-314 (1989).
27. C.G. ROSSI, Y-X. PAN, G.P. BROWN, and G. PASTERNAK, FEBS Lett. 369 192-196 (1995).
28. A.S. MOSKOWITZ and R.R. GOODMAN, Brain Res. 360 117-129 (1985).